FCMI
GRTS

Foresite Capital Management IV’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Foresite Capital Management IV’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-175,000
Closed -$2.49M – 25
2018
Q3 		$2.49M Buy
+175,000
New +$2.49M 0.82% 17

Other funds holding GRTS

PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Foresite Capital Management IV's GRTS Position: Q4 2018 in Review

Foresite Capital Management IV sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2018, closing a stake of 175,000 shares — an estimated $2.49M sold.

Foresite Capital Management IV first reported a position in GRTS in Q3 2018 and held it in 1 quarter. The position peaked at $2.49M in Q3 2018. 52 funds tracked by Wall St. Rank hold GRTS as of Q4 2018.

  • Foresite Capital Management IV reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Foresite Capital Management IV sold 175,000 Gritstone bio, Inc. Common Stock shares in Q4 2018, an estimated $2.49M.
  • Foresite Capital Management IV first reported a position in Gritstone bio, Inc. Common Stock in Q3 2018 and held it in 1 quarter.
  • Foresite Capital Management IV's Gritstone bio, Inc. Common Stock position peaked at $2.49M in Q3 2018.
  • 52 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2018.

Based on Foresite Capital Management IV's 13F filing for Q4 2018, filed 13 Feb 2019.